Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Systematic Identification of Oncogenic EGFR Interaction Partners.

Petschnigg J, Kotlyar M, Blair L, Jurisica I, Stagljar I, Ketteler R.

J Mol Biol. 2017 Jan 20;429(2):280-294. doi: 10.1016/j.jmb.2016.12.006.

2.

TACC3 promotes colorectal cancer tumourigenesis and correlates with poor prognosis.

Du Y, Liu L, Wang C, Kuang B, Yan S, Zhou A, Wen C, Chen J, Wu Y, Yang X, Feng G, Liu B, Iwamoto A, Zeng M, Wang J, Zhang X, Liu H.

Oncotarget. 2016 Jul 5;7(27):41885-41897. doi: 10.18632/oncotarget.9628.

3.

Multivariate models from RNA-Seq SNVs yield candidate molecular targets for biomarker discovery: SNV-DA.

Paul MR, Levitt NP, Moore DE, Watson PM, Wilson RC, Denlinger CE, Watson DK, Anderson PE.

BMC Genomics. 2016 Mar 31;17:263. doi: 10.1186/s12864-016-2542-4.

4.

TACC3 promotes stemness and is a potential therapeutic target in hepatocellular carcinoma.

Zhou DS, Wang HB, Zhou ZG, Zhang YJ, Zhong Q, Xu L, Huang YH, Yeung SC, Chen MS, Zeng MS.

Oncotarget. 2015 Sep 15;6(27):24163-77.

5.
6.

TACC3 is essential for EGF-mediated EMT in cervical cancer.

Ha GH, Kim JL, Breuer EK.

PLoS One. 2013 Aug 1;8(8):e70353. doi: 10.1371/journal.pone.0070353. Erratum in: PLoS One. 2013;8(9). doi:10.1371/annotation/23c9bde1-5ced-4eb9-8a73-c53f3f2913d4. Breuer, Eun-Kyoung Yim [corrected to Breuer, Eun-Kyoung].

7.

The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma.

Parker BC, Annala MJ, Cogdell DE, Granberg KJ, Sun Y, Ji P, Li X, Gumin J, Zheng H, Hu L, Yli-Harja O, Haapasalo H, Visakorpi T, Liu X, Liu CG, Sawaya R, Fuller GN, Chen K, Lang FF, Nykter M, Zhang W.

J Clin Invest. 2013 Feb;123(2):855-65. doi: 10.1172/JCI67144.

8.

Oncogenic FGFR3 gene fusions in bladder cancer.

Williams SV, Hurst CD, Knowles MA.

Hum Mol Genet. 2013 Feb 15;22(4):795-803. doi: 10.1093/hmg/dds486.

9.

Multiple cancer testis antigens function to support tumor cell mitotic fidelity.

Cappell KM, Sinnott R, Taus P, Maxfield K, Scarbrough M, Whitehurst AW.

Mol Cell Biol. 2012 Oct;32(20):4131-40.

10.

MoMuLV-ts-1: A Unique Mouse Model of Retrovirus-Induced Lymphoma Transmitted by Breast Milk.

Chakraborty J, Okonta H, Bagalb H, Duggan J.

Adv Virol. 2011;2011:813651. doi: 10.1155/2011/813651.

11.

Tumor suppressors and cell-cycle proteins in lung cancer.

Baldi A, De Luca A, Esposito V, Campioni M, Spugnini EP, Citro G.

Patholog Res Int. 2011;2011:605042. doi: 10.4061/2011/605042.

12.

Integrated genomic analyses identify ERRFI1 and TACC3 as glioblastoma-targeted genes.

Duncan CG, Killela PJ, Payne CA, Lampson B, Chen WC, Liu J, Solomon D, Waldman T, Towers AJ, Gregory SG, McDonald KL, McLendon RE, Bigner DD, Yan H.

Oncotarget. 2010 Aug;1(4):265-77.

13.

Role of cell cycle regulators in lung carcinogenesis.

Eymin B, Gazzeri S.

Cell Adh Migr. 2010 Jan-Mar;4(1):114-23. Review.

14.

Identification of differentially expressed proteins in spontaneous thymic lymphomas from knockout mice with deletion of p53.

Honor√© B, Buus S, Cla√ęsson MH.

Proteome Sci. 2008 Jun 10;6:18. doi: 10.1186/1477-5956-6-18.

15.

Interaction of TACC proteins with the FHL family: implications for ERK signaling.

Lauffart B, Sondarva GV, Gangisetty O, Cincotta M, Still IH.

J Cell Commun Signal. 2007 Jun;1(1):5-15. doi: 10.1007/s12079-007-0001-3.

Supplemental Content

Support Center